CYP4A11 and metabolic dysfunction-associated steatotic liver disease: Notably, we found that CYP4A11, previously associated with NAFLD [72,73], is highly up-regulated in both humans and mice, possibly indicating a causative role in NASH development due to PFAS exposure.